Summary of head‐to‐head comparisons of patient risk classifications by the 21‐gene Recurrence Score® (RS) assay and other genomic assays for early breast cancer

Zsuzsanna Varga; Peter Sinn; Andrew D. Seidman

doi:10.1002/ijc.32139

Summary of head‐to‐head comparisons of patient risk classifications by the 21‐gene Recurrence Score® (RS) assay and other genomic assays for early breast cancer

International Journal of Cancer ◽

10.1002/ijc.32139 ◽

2019 ◽

Vol 145 (4) ◽

pp. 882-893 ◽

Cited By ~ 9

Author(s):

Zsuzsanna Varga ◽

Peter Sinn ◽

Andrew D. Seidman

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Recurrence Score ◽

Patient Risk ◽

Genomic Assays

Download Full-text

Summary of head-to-head comparisons of patient (pt) risk classifications by the 21-gene recurrence score (RS) assay and other genomic assays for early breast cancer (EBC)

Annals of Oncology ◽

10.1093/annonc/mdx362.037 ◽

2017 ◽

Vol 28 ◽

pp. v57

Author(s):

Z. Varga ◽

P. Sinn ◽

D. McCullough ◽

A. Lau ◽

M.C. Stöppler ◽

...

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Recurrence Score ◽

Genomic Assays

Download Full-text

A summary of head-to-head comparisons of patient (pt) risk classifications by the 21-gene Recurrence Score® (RS) assay and other genomic assays for early breast cancer (EBC)

The Breast ◽

10.1016/s0960-9776(17)30313-2 ◽

2017 ◽

Vol 32 ◽

pp. S98

Author(s):

Z. Varga ◽

D. McCullough ◽

A. Lau ◽

M. Stöppler ◽

F.L. Baehner ◽

...

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Recurrence Score ◽

Genomic Assays

Download Full-text

Abstract GS4-10: Development and validation of a tool integrating the 21-gene recurrence score and clinicopathlogic features to individualize prognosis for distant recurrence and prediction of absolute chemotherapy benefit in early breast cancer

10.1158/1538-7445.sabcs20-gs4-10 ◽

2021 ◽

Author(s):

Joseph A Sparano ◽

Michael R Crager ◽

Gong Tang ◽

Robert J Gray ◽

Salomon M Stemmer ◽

...

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Recurrence Score ◽

Distant Recurrence ◽

Development And Validation

Download Full-text

Abstract GS4-04: Endocrine therapy alone in patients with intermediate or high-risk luminal early breast cancer (0-3 lymph nodes), Recurrence Score <26 and Ki67 response after preoperative endocrine therapy: Primary outcome results from the WSG-ADAPT HR+/HER2- trial

10.1158/1538-7445.sabcs20-gs4-04 ◽

2021 ◽

Author(s):

Nadia Harbeck ◽

Oleg Gluz ◽

Sherko Kuemmel ◽

Matthias Christgen ◽

Michael Braun ◽

...

Keyword(s):

Breast Cancer ◽

High Risk ◽

Lymph Nodes ◽

Endocrine Therapy ◽

Early Breast Cancer ◽

Primary Outcome ◽

Recurrence Score

Download Full-text

Distribution patterns of 21-gene recurrence score in 980 Chinese estrogen receptor-positive, HER2-negative early breast cancer patients

Oncotarget ◽

10.18632/oncotarget.16313 ◽

2017 ◽

Vol 8 (24) ◽

pp. 38706-38716 ◽

Cited By ~ 11

Author(s):

Jiayi Wu ◽

Yan Fang ◽

Lin Lin ◽

Xiaochun Fei ◽

Weiqi Gao ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Patients ◽

Early Breast Cancer ◽

Recurrence Score ◽

Distribution Patterns ◽

Breast Cancer Patients ◽

Estrogen Receptor Positive

Download Full-text

First prospective multicenter Italian study on the impact of the 21-gene recurrence score (RS) in adjuvant clinical decisions for ER+/HER2- early breast cancer (BC) patients

Annals of Oncology ◽

10.1093/annonc/mdx424.019 ◽

2017 ◽

Vol 28 ◽

pp. vi31

Author(s):

M.V. Dieci ◽

V. Guarneri ◽

T. Giarratano ◽

M. Mion ◽

G. Tortora ◽

...

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Recurrence Score ◽

Clinical Decisions ◽

Italian Study ◽

The Impact

Download Full-text

Abstract P2-10-08: Prospective comparison of Recurrence Score and different definitions of luminal subtypes by central pathology assessment of single markers in early breast cancer: results from the phase III WSG-planB Trial

10.1158/0008-5472.sabcs12-p2-10-08 ◽

2012 ◽

Cited By ~ 1

Author(s):

O Gluz ◽

HH Kreipe ◽

RE Kates ◽

M Christgen ◽

C Liedtke ◽

...

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Recurrence Score ◽

Phase Iii ◽

Prospective Comparison ◽

Central Pathology

Download Full-text

Abstract P2-18-06: Value of PAM50 risk of recurrence score in patients with HR positive HER2 negative early breast cancer and intermediate risk: A single cancer center institution prospective observational study

10.1158/1538-7445.sabcs19-p2-18-06 ◽

2020 ◽

Author(s):

Vincent Nicolaï ◽

Julia Gilhodes ◽

Jean Louis Lacaze ◽

Mony Ung ◽

Eleonora De Maio ◽

...

Keyword(s):

Breast Cancer ◽

Observational Study ◽

Early Breast Cancer ◽

Prospective Observational Study ◽

Recurrence Score ◽

Cancer Center ◽

Intermediate Risk ◽

Risk Of Recurrence ◽

Single Cancer

Download Full-text

Ki67 as an important predictor for oncotype Dx recurrence score risk groups in early breast cancer

Annals of Oncology ◽

10.1093/annonc/mdy270.209 ◽

2018 ◽

Vol 29 ◽

pp. viii68

Author(s):

F. Namuche ◽

R.E. Ruiz ◽

Z.D. Morante Cruz ◽

D. Urrunaga ◽

A. Aguilar Cartagena ◽

...

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Recurrence Score ◽

Risk Groups ◽

Oncotype Dx ◽

Important Predictor ◽

Oncotype Dx Recurrence Score ◽

Score Risk

Download Full-text

Comparison of GenesWell BCT Score With Oncotype DX Recurrence Score for Risk Classification in Asian Women With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer

Frontiers in Oncology ◽

10.3389/fonc.2019.00667 ◽

2019 ◽

Vol 9 ◽

Cited By ~ 2

Author(s):

Mi Jeong Kwon ◽

Jeong Eon Lee ◽

Joon Jeong ◽

Sang Uk Woo ◽

Jinil Han ◽

...

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Hormone Receptor ◽

Recurrence Score ◽

Risk Classification ◽

Oncotype Dx ◽

Asian Women ◽

Hormone Receptor Positive ◽

Oncotype Dx Recurrence Score

Download Full-text